SCHEMBL29374346

SCHEMBL29374346

C=C(C=O)CC1CC(O)[C@]2(C)OC3CC4OC5C[C@]6(C)O[C@]7(C)CCC8OC9C[C@]%10(C)OC%11C(C)=CC(=O)OC%11CC%10OC9C[C@@H](C)C8OC7CC6O[C@]5(C)CC5OC5C4OC3CC2O1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 1.00
NPSR1 Q6W5P4 3/20 1.00
NPC1 O15118 2/20 1.00
MAPT P10636 2/20 1.00
MAPK1 P28482 2/20 1.00
RAB9A P51151 2/20 1.00
XBP1 P17861 1/20 1.00
SCN1A P35498 1/20 0.86
SCN2A Q99250 1/20 0.86
SCN3A Q9NY46 1/20 0.86
PDE4D Q08499 3/20 0.81
MEN1 O00255 1/20 0.74
KMT2A Q03164 1/20 0.74
POLB P06746 1/20 0.70
CRHBP P24387 1/20 0.66
CRHR2 Q13324 1/20 0.66
HTT P42858 1/20 0.44
ATM Q13315 1/20 0.44
RAP1A P62834 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14043530 1.00 ALDH1A1 (1.00) ALDH1A1NPSR1NPC1MAPTMAPK1
SCHEMBL13947382 0.93 ALDH1A1 (0.86) ALDH1A1NPSR1NPC1MAPTMAPK1
Alpha-Bungarotoxin SCHEMBL29366348 0.93 SCN1A (1.00) ALDH1A1NPSR1NPC1MAPTMAPK1
Alpha-Bungarotoxin SCHEMBL29386702 0.93 SCN1A (1.00) ALDH1A1NPSR1NPC1MAPTMAPK1
Alpha-Bungarotoxin SCHEMBL29374938 0.93 SCN1A (1.00) ALDH1A1NPSR1NPC1MAPTMAPK1
Alpha-Bungarotoxin SCHEMBL29381923 0.93 SCN1A (1.00) ALDH1A1NPSR1NPC1MAPTMAPK1
Alpha-Bungarotoxin SCHEMBL14043478 0.93 SCN1A (1.00) ALDH1A1NPSR1NPC1MAPTMAPK1
Brevetoxin B SCHEMBL869360 0.93 SCN1A (1.00) ALDH1A1NPSR1NPC1MAPTMAPK1
Alpha-Bungarotoxin SCHEMBL14106557 0.93 SCN1A (1.00) ALDH1A1NPSR1NPC1MAPTMAPK1
SCHEMBL12908960 0.92 ALDH1A1 (0.85) ALDH1A1NPSR1NPC1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12350260-B2 Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning UNIVERSITE DE BRETAGNE OCCIDENTALE (FR) 2025-07-08 US disclosed
CN-111138447-B B-group hapten, artificial antigen and monoclonal antibody of Gymnodinium breve toxin, and preparation method and application thereof 国家海洋环境监测中心 2022-09-06 CN disclosed
US-20220193048-A1 PROTEASE-ACTIVATED RECEPTOR-2 INHIBITORS FOR THE TREATMENT OF SENSORY NEUROPATHY INDUCED BY A MARINE NEUROTOXIC POISONING UNIVERSITE DE BRETAGNE OCCIDENTALE (FR) 2022-06-23 US disclosed
EP-3946332-A1 PROTEASE-ACTIVATED RECEPTOR-2 INHIBITORS FOR THE TREATMENT OF SENSORY NEUROPATHY INDUCED BY A MARINE NEUROTOXIC POISONING Université de Bretagne Occidentale (FR) 2022-02-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220193048-A1 PROTEASE-ACTIVATED RECEPTOR-2 INHIBITORS FOR THE TREATMENT OF SENSORY NEUROPATHY INDUCED BY A MARINE NEUROTOXIC POISONING PRSS12, TPSB2, F2RL1 ALDH1A1 2394/4885NPSR1 76/4885NPC1 2326/4885
US-12350260-B2 Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning PRSS12, TPSB2, F2RL1 ALDH1A1 2394/4885NPSR1 76/4885NPC1 2326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.